Journal article icon

Journal article

Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study.

Abstract:

BACKGROUND: The median survival for patients with glioblastoma is reported to be 12 months. To improve the outcome for glioblastoma patients, the authors evaluated the therapeutic efficacy of preirradiation gemcitabine chemotherapy followed by standard radiotherapy. METHODS: Twenty-one patients with newly diagnosed glioblastoma were enrolled in a prospective unicenter trial of preirradiation gemcitabine chemotherapy. Chemotherapy included up to 4 monthly cycles of intravenous gemcitabine (Da...

Expand abstract

Actions


Access Document


Authors


Streffer, J More by this author
Kortmann, RD More by this author
Expand authors...
Journal:
Cancer
Volume:
91
Issue:
2
Pages:
423-427
Publication date:
2001-01-05
DOI:
EISSN:
1097-0142
ISSN:
0008-543X
URN:
uuid:a788f99b-d0d2-42d3-a896-8979e93ce922
Source identifiers:
241965
Local pid:
pubs:241965

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP